Wolverine Trading, LLC Incyte Corp Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Incyte Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 18,400 shares of INCY stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,400

Previous 5,142 257.84%

Holding current value

$1.3 Million

Previous $311,000 291.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $263,167 - $327,802	5,142 New	5,142 $311,000
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $14,040 - $17,578	-209 Reduced 6.51%	2,999 $241,000
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $14,294 - $17,897	216 Added 7.22%	3,208 $214,000
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $388,608 - $488,432	-5,872 Reduced 66.25%	2,992 $227,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $617,184 - $722,127	-9,744 Reduced 52.36%	8,864 $657,000
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $833,722 - $1.02 Million	12,141 Added 187.74%	18,608 $1.28 Million
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $134,660 - $147,575	1,686 Added 35.26%	6,467 $548,000
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $622,907 - $823,497	-8,194 Reduced 63.15%	4,781 $384,000
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $187,420 - $245,617	2,566 Added 24.65%	12,975 $1.14 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $24,613 - $29,243	338 Added 3.36%	10,409 $758,000
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $353,827 - $425,337	-5,730 Reduced 36.26%	10,071 $696,000
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $593,357 - $739,477	6,342 Added 67.05%	15,801 $1.5 Million
Q3 2017 Nov 15, 2017	BUY	$109.15 - $138.27 $1.03 Million - $1.31 Million	9,459	9,459 $1.1 Million

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Incyte Corp Transaction History